Silverarc Capital Management as of Dec. 31, 2020
Portfolio Holdings for Silverarc Capital Management
Silverarc Capital Management holds 84 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vericel (VCEL) | 5.0 | $8.7M | 281k | 30.88 | |
| Biogen Call Call Option | 4.3 | $7.3M | 30k | 244.87 | |
| Intra Cellular Therapies (ITCI) | 3.7 | $6.4M | 200k | 31.80 | |
| Delcath Sys Com New (DCTH) | 3.7 | $6.3M | 352k | 17.92 | |
| Insmed Com Par $.01 (INSM) | 3.4 | $5.8M | 175k | 33.29 | |
| Amryt Pharma Sponsored Ads | 3.3 | $5.7M | 403k | 14.16 | |
| Dicerna Pharmaceuticals | 2.9 | $5.0M | 227k | 22.03 | |
| Arvinas Ord (ARVN) | 2.7 | $4.7M | 55k | 84.93 | |
| Larimar Therapeutics (LRMR) | 2.7 | $4.6M | 217k | 21.41 | |
| Immunovant (IMVT) | 2.7 | $4.6M | 100k | 46.19 | |
| Mirati Therapeutics | 2.6 | $4.4M | 20k | 219.65 | |
| Curis Com New | 2.5 | $4.3M | 530k | 8.19 | |
| Halozyme Therapeutics (HALO) | 2.5 | $4.3M | 100k | 42.71 | |
| Tcr2 Therapeutics Inc cs | 2.4 | $4.2M | 136k | 30.93 | |
| Sutro Biopharma (STRO) | 2.3 | $4.0M | 185k | 21.71 | |
| ImmunoGen | 2.2 | $3.9M | 600k | 6.45 | |
| Essa Pharma Com New (EPIX) | 2.2 | $3.9M | 323k | 11.93 | |
| Cellectar Biosciences Com Par | 2.1 | $3.7M | 1.8M | 2.08 | |
| Chemocentryx | 1.9 | $3.3M | 54k | 61.92 | |
| Kura Oncology (KURA) | 1.7 | $2.9M | 90k | 32.66 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.7 | $2.9M | 18k | 166.78 | |
| Jounce Therapeutics | 1.7 | $2.8M | 407k | 7.00 | |
| Evogene SHS (EVGN) | 1.6 | $2.8M | 600k | 4.70 | |
| Cogent Biosciences (COGT) | 1.5 | $2.6M | 235k | 11.23 | |
| Helix Acquisition Corp Com Cl A | 1.4 | $2.4M | 215k | 11.37 | |
| Guardant Health (GH) | 1.4 | $2.4M | 19k | 128.87 | |
| Verastem | 1.4 | $2.4M | 1.1M | 2.13 | |
| Affimed Therapeutics B V | 1.4 | $2.3M | 400k | 5.82 | |
| Renalytix Ai Ads (RNLX) | 1.3 | $2.3M | 141k | 16.00 | |
| Deciphera Pharmaceuticals (DCPH) | 1.3 | $2.2M | 39k | 57.07 | |
| Horizon Therapeutics Pub L SHS | 1.3 | $2.2M | 30k | 73.17 | |
| Sierra Oncology Com New | 1.3 | $2.2M | 135k | 16.03 | |
| Turning Point Therapeutics I | 1.1 | $2.0M | 16k | 121.88 | |
| Adamas Pharmaceuticals | 1.1 | $1.9M | 441k | 4.33 | |
| Compugen Ord (CGEN) | 1.1 | $1.8M | 151k | 12.11 | |
| Morphic Hldg (MORF) | 1.0 | $1.7M | 51k | 33.56 | |
| Otonomy | 1.0 | $1.7M | 264k | 6.47 | |
| Trillium Therapeutics Com New | 0.9 | $1.6M | 110k | 14.71 | |
| Arena Pharmaceuticals Com New | 0.9 | $1.5M | 20k | 76.85 | |
| Zymeworks | 0.8 | $1.5M | 31k | 47.25 | |
| Nextcure (NXTC) | 0.8 | $1.4M | 130k | 10.90 | |
| Biohaven Pharmaceutical Holding | 0.8 | $1.4M | 17k | 85.70 | |
| Celldex Therapeutics Com New (CLDX) | 0.8 | $1.4M | 80k | 17.53 | |
| Seagen | 0.8 | $1.3M | 7.5k | 175.12 | |
| Scholar Rock Hldg Corp (SRRK) | 0.7 | $1.2M | 25k | 48.52 | |
| Surface Oncology | 0.7 | $1.2M | 130k | 9.24 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.7 | $1.2M | 5.0k | 236.40 | |
| 89bio (ETNB) | 0.6 | $1.1M | 44k | 24.36 | |
| Kadmon Hldgs | 0.6 | $1.0M | 242k | 4.15 | |
| Mereo Biopharma Group Ads (MREO) | 0.6 | $1.0M | 280k | 3.58 | |
| Nkarta (NKTX) | 0.5 | $922k | 15k | 61.47 | |
| Akero Therapeutics (AKRO) | 0.5 | $908k | 35k | 25.81 | |
| Iveric Bio | 0.5 | $899k | 130k | 6.91 | |
| BioCryst Pharmaceuticals (BCRX) | 0.5 | $820k | 110k | 7.45 | |
| United Therapeutics Corporation (UTHR) | 0.5 | $814k | 5.4k | 151.75 | |
| Alexion Pharmaceuticals | 0.5 | $781k | 5.0k | 156.20 | |
| Ardelyx (ARDX) | 0.5 | $776k | 120k | 6.47 | |
| Calithera Biosciences Call Call Option | 0.4 | $737k | 150k | 4.91 | |
| Biogen Idec (BIIB) | 0.4 | $735k | 3.0k | 245.00 | |
| Constellation Pharmceticls I | 0.4 | $726k | 25k | 28.81 | |
| Actinium Pharmaceuticals (ATNM) | 0.4 | $702k | 90k | 7.80 | |
| Kala Pharmaceuticals | 0.4 | $693k | 102k | 6.78 | |
| Syndax Pharmaceuticals (SNDX) | 0.4 | $667k | 30k | 22.23 | |
| EXACT Sciences Corporation (EXAS) | 0.4 | $662k | 5.0k | 132.40 | |
| Soleno Therapeutics Com New | 0.4 | $623k | 323k | 1.93 | |
| Leap Therapeutics | 0.4 | $619k | 275k | 2.25 | |
| Seres Therapeutics (MCRB) | 0.4 | $613k | 25k | 24.52 | |
| Gamida Cell SHS (GMDA) | 0.3 | $594k | 71k | 8.38 | |
| Vyne Therapeutics Com New | 0.3 | $552k | 350k | 1.58 | |
| Rocket Pharmaceuticals (RCKT) | 0.3 | $548k | 10k | 54.80 | |
| Therapeutics Acquisition Cor Com Cl A | 0.3 | $543k | 39k | 13.92 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.3 | $519k | 10k | 51.90 | |
| Medicenna Therapeutics Corp. (MDNAF) | 0.3 | $503k | 108k | 4.68 | |
| Iovance Biotherapeutics (IOVA) | 0.3 | $464k | 10k | 46.40 | |
| Protagonist Therapeutics (PTGX) | 0.2 | $422k | 21k | 20.18 | |
| Aptinyx | 0.2 | $372k | 108k | 3.46 | |
| Mersana Therapeutics (MRSN) | 0.2 | $286k | 11k | 26.57 | |
| Compugen Call Call Option | 0.1 | $242k | 20k | 12.10 | |
| Arcutis Biotherapeutics (ARQT) | 0.1 | $239k | 8.5k | 28.10 | |
| Fulcrum Therapeutics (FULC) | 0.1 | $190k | 16k | 11.72 | |
| Chardan Healthcare Acqu- Ord (PHGE) | 0.1 | $88k | 14k | 6.40 | |
| Calithera Biosciences | 0.0 | $74k | 15k | 4.93 | |
| Chardan Healthcr Acqstn 2 *w Exp 03/05/202 | 0.0 | $49k | 99k | 0.50 | |
| Bionano Genomics *w Exp 08/21/202 | 0.0 | $21k | 10k | 2.10 |
